PTC Therapeutics
PTCT
#2999
Rank
โ‚น548.41 B
Marketcap
โ‚น6,571
Share price
-0.01%
Change (1 day)
43.36%
Change (1 year)

PTC Therapeutics (PTCT) - Total liabilities

Total liabilities on the balance sheet as of March 2026 : โ‚น290.03 Billion

According to PTC Therapeutics 's latest financial reports the company's total liabilities are โ‚น290.03 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

PTC Therapeutics - Total liabilities on balance sheet (from 2012 to 2026)

Total liabilities by year

Year Total liabilities Change
2025-12-31โ‚น278.65 B15.88%
2024-12-31โ‚น240.46 B6.42%
2023-12-31โ‚น225.95 B33.03%
2022-12-31โ‚น169.86 B17.84%
2021-12-31โ‚น144.14 B14.17%
2020-12-31โ‚น126.25 B71.98%
2019-12-31โ‚น73.41 B36.62%
2018-12-31โ‚น53.73 B257.79%
2017-12-31โ‚น15.01 B47.57%
2016-12-31โ‚น10.17 B9.95%
2015-12-31โ‚น9.25 B320.24%
2014-12-31โ‚น2.20 B132.09%
2013-12-31โ‚น0.94 B-46.28%
2012-12-31โ‚น1.76 B-88.19%
2011-12-31โ‚น14.95 B

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Novartis
NVS
โ‚น7.570 T 2,510.37%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Vertex Pharmaceuticals
VRTX
โ‚น677.39 B 133.56%๐Ÿ‡บ๐Ÿ‡ธ USA
Xencor
XNCR
โ‚น21.03 B-92.75%๐Ÿ‡บ๐Ÿ‡ธ USA
Sarepta Therapeutics
SRPT
โ‚น159.19 B-45.11%๐Ÿ‡บ๐Ÿ‡ธ USA
Fate Therapeutics
FATE
โ‚น10.00 B-96.55%๐Ÿ‡บ๐Ÿ‡ธ USA
Avidity Biosciences
RNAM
โ‚น25.62 B-91.16%๐Ÿ‡บ๐Ÿ‡ธ USA